Published Medical Novel Immune Activators A promising target for first-in-class immunotherapies that stimulate the increase of CTL numbers by up to 5 times By Imperial Innovations
Published Medical Reducing toxicity ALDH2 activator compounds could potentially be used to preventively to reduce damage from ischemia, Alzheimer's disease, Parkinson's disease, alcohol-induced liver cirrhosis, etc. By Stanford University
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
